Pharmaceuticals Native Starch Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Current Pharmaceuticals Native Starch Market Size and Its Estimated Growth Rate?
The size of the native starch market in the pharmaceutical sector has witnessed robust growth in the past few years. The market size is expected to surge from $5.65 billion in 2024 to $6.17 billion in 2025, recording a compound annual growth rate (CAGR) of 9.1%. The increase during the historic period is linked to a higher demand for natural excipients, escalation in pharmaceutical production, a boosted preference for biocompatible ingredients, the expansion of generic medication manufacturing, and increasing regulatory backing for natural substances.

The market size of native starch in the pharmaceuticals sector is poised for a substantial escalation in the coming years, potentially reaching $8.69 billion by 2029 with a CAGR of 8.9%. This predicted growth during the forecasted timespan can be ascribed to increased funding into innovation within the pharmaceutical industry, a heightened emphasis on green procurement, broader utilization in unique drug configurations, surging demand for pharmaceutical items with clean labels and elevating healthcare expenditure within developing economies. Foreseen trends during this period encompass progress in starch processing technologies, breakthroughs in drug delivery mechanisms, the evolution of bio-based pharmaceutical components, R&D in plant-derived excipients and the creation of solutions for solubility and stability.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

How Are Emerging Segments Shaping the Pharmaceuticals Native Starch Market Landscape?
The pharmaceuticals native starch market covered in this report is segmented -

1) By Type: Potato Starch, Corn Starch, Other Types
2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:
1) By Potato Starch: Modified Potato Starch, Native Potato Starch
2) By Corn Starch: Modified Corn Starch, Native Corn Starch
3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Growth Factors Are Influencing Pharmaceuticals Native Starch Market Expansion?
The escalating occurrence of persistent illnesses is projected to drive the expansion of the pharmaceuticals native starch market. Such diseases are enduring medical issues that generally evolve slowly and last for at least a year. The rising occurrence of such ailments can primarily be related to the growing population of elderly people, as they are more prone to long-term ailments like diabetes, cardiovascular issues, arthritis, and cancer, which increase with age. Pharmaceuticals native starch plays a beneficial role in persistent diseases by enhancing the stability of drug formulation, improving bioavailability, facilitating controlled drug release, promoting patient compliance, and ultimately amplifying the effectiveness and long-term management of enduring health conditions. For instance, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in June 2024 that there was an increase in the mortality rate from persistent conditions, rising from 459 per 100,000 individuals in 2021 to 490 per 100,000 individuals in 2022. Therefore, the escalating occurrence of persistent illnesses is stimulating the expansion of the pharmaceuticals native starch market.

Who Are the Dominant Players Across Different Pharmaceuticals Native Starch Market Segments?
Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

What Trends Are Driving Growth in The Pharmaceuticals Native Starch Market?
Leading firms in the native starch market for pharmaceuticals are concentrating on the creation of novel products like plant-derived textures to enrich drug formulation and better patient adherence. Plant-derived texture implies the physical attributes obtained from plant constituents, such as viscosity and gel strength, facilitating the usage of native starch in pharmaceuticals by improving tablet adhesion, disintegration, and a pleasing sensation in the mouth for enhanced natural drug formulations. For example, in February 2024, Ingredion Incorporated, a food company based in the US, introduced Novation Indulge 2940 starch, an innovative texturizer with a clean-label, engineered to augment texture and stability in dairy and alternative dairy goods. This pioneering pharmaceutical native starch provides functional attributes that enrich drug formulation efficacy, bioavailability, and controlled release while fostering the creation of sustainable products with clean labels. NOVATION Indulge 2940 starch is a multipurpose component that enhances texture, stability, and consumer approval in both dairy and dairy alternative products, using natural, clean-label ingredients.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Geographic Regions Are Expected to Dominate the Pharmaceuticals Native Starch Market in the Coming Years?
North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pharmaceuticals Native Starch Market?
2. What is the CAGR expected in the Pharmaceuticals Native Starch Market?
3. What Are the Key Innovations Transforming the Pharmaceuticals Native Starch Industry?
4. Which Region Is Leading the Pharmaceuticals Native Starch Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.